Search Results for 'Cisplatin-Docetaxel'

Cisplatin-Docetaxel published presentations and documents on DocSlides.

Second line  treatments  in WT
Second line treatments in WT
by deena
pts. : . which. . opportunities. with . biologic...
What is the reference  cytotoxic
What is the reference cytotoxic
by pasty-toler
regimen in advanced gastric cancer?. Florian Lor...
Second line
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Docetaxel 100 Mg M2
Docetaxel 100 Mg M2
by stefany-barnette
docetaxel price usa. docetaxel injection ip monog...
Alkylating Agents Dr.Muhammad
Alkylating Agents Dr.Muhammad
by seth389
Albaghdadi. Oncologist. HISTORY. Mechlorethamine. ...
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
by finley
Università . di Napoli “Federico II”. Innovat...
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
by ceila
Jeanny B. Aragon-Ching, M.D., F.A.C.P.. Clinical P...
Bladder Cancer: An Overview of Treatment
Bladder Cancer: An Overview of Treatment
by fanny
Lori Wood, MD, MSc, FRCPC. Medical Oncologist, Que...
Providedby
Providedby
by linda
MedulloblastomaLeadcontributors:IraDunkel,MDIntrod...
PACKAGE LEAFLET INFORMATION FOR THE USER
PACKAGE LEAFLET INFORMATION FOR THE USER
by josephine
Page 1 of 7 Cisplatin 1 mg/ml Sterile Concentrat...
In the name of God Platinium
In the name of God Platinium
by DiamondsAreForever
compounds. Gathered & presented . by:F.malek. ...
Kidney & cancers Dr.Sh.Sajjadieh
Kidney & cancers Dr.Sh.Sajjadieh
by PinkPandaBear
nephrologist. Urinary Obstruction. Urinary obstruc...
Thomas E. Keane  Medical University of South Carolina
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
For the Patient: GIPEPalliative therapy of neuroendocrine tumours usin
For the Patient: GIPEPalliative therapy of neuroendocrine tumours usin
by anastasia
ABOUT THIS MEDICATION What are these drugs used fo...
Corporate Presentation September
Corporate Presentation September
by terrificycre
2013. Safe Harbor Statement. During the course of ...
Thomas E. Keane
Thomas E. Keane
by danika-pritchard
Medical University of South Carolina . Charleston...
L’algoritmo terapeutico
L’algoritmo terapeutico
by calandra-battersby
attraverso . i . c. asi clinici. Giuseppe . Valma...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by cheryl-pisano
Moderator. Neil Love, MD. A Oliver Sartor, MD. Vi...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
Striving for Consensus on the
Striving for Consensus on the
by samantha
Optimal Management of Metastatic . Non-Small Cell ...
Meeting summary ASCO GU 2020,
Meeting summary ASCO GU 2020,
by patricia
San Francisco. , USA. Assoc. . Prof. . Shilpa Gupt...
1 Svetlana Jeremić 1 , Ana Kesić
1 Svetlana Jeremić 1 , Ana Kesić
by esther
2. , Jelena Đorović Jovanović. 2. , Biljana Pet...
Module 6:  Prostate Cancer
Module 6: Prostate Cancer
by payton
Victoria . Sinibaldi. , RN, MS, CS, CANP, BC. Dani...
conclusions Folfiri  or
conclusions Folfiri or
by victoria
Folfox. in second line advanced of biliary tract ...
F igure  S1 . Enrichment of one of the markers results in enrichment of the other markers.
F igure S1 . Enrichment of one of the markers results in enrichment of the other markers.
by candy
(. A. ) HepG2 cells were enriched for CD90 and (. ...
School  of Pharmaceutical
School of Pharmaceutical
by amber
science. 1. Topic – Antiemetic . Screening Mod...
Multidisciplinary approach         to lung cancer
Multidisciplinary approach to lung cancer
by elena
Kamil Konopka. Department of Oncology, University ...
Paradigm Shift in the Management of  Metastatic Castration-Sensitive                 Prostate Cance
Paradigm Shift in the Management of Metastatic Castration-Sensitive Prostate Cance
by luna
m. CSPC). 1. Neal Shore, MD, FACS. Carolina Urolog...
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
by christina
Marsden internal audit – FN 35% with FEC-T (19. ...
Lec . 4    Drugs from plants
Lec . 4 Drugs from plants
by jalin
:. * Medicinal plants have been used as a major so...
x0000x0000ADULT
x0000x0000ADULT
by reese
Please refer to CCMB Formulary for Criteria for Us...
Management of gastric cancer
Management of gastric cancer
by elizabeth
THEME Reprinted from Australian Family Physician ...
Cervical Cancer Definitive
Cervical Cancer Definitive
by bety
Chemoradiation Huma Chaudhry Jordan Kharofa Facul...
Chemotherapy and Radiotherapy
Chemotherapy and Radiotherapy
by PeacefulPassion
Dr. . Sura. . Findakly. MBChB. ,. DGO,. CABOG. Le...
Anti-Inflammatory and Anti-Cancer effects of thioalkaloids from
Anti-Inflammatory and Anti-Cancer effects of thioalkaloids from
by kylie
Nuphar lutea . (yellow Water Lilly).. MCF-7 Breast...
Best practice for chemotherapy for treatment of breast cancer
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Non-small-cell lung cancer
Non-small-cell lung cancer
by piper
DR.Mohammed Awad. Incidence. The most common cause...
British Journal of Cancer 1995 72 10161019  1995 Stockton Press All r
British Journal of Cancer 1995 72 10161019 1995 Stockton Press All r
by megan
1 V Levy2 G Rustin 3 T Perren4 AH Calvert5 H Earl6...
paclitaxel should be administered
paclitaxel should be administered
by thomas
12 Reference ID 2939751 mor activity TAXOL paclita...